Strides Pharma Science consolidated net profit rises 77.52% in the September 2025 quarter
Sales rise 4.62% to Rs 1220.83 crore
Net profit of Strides Pharma Science rose 77.52% to Rs 127.53 crore in the quarter ended September 2025 as against Rs 71.84 crore during the previous quarter ended September 2024. Sales rose 4.62% to Rs 1220.83 crore in the quarter ended September 2025 as against Rs 1166.93 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales1220.831166.93 5 OPM %18.8815.76 -PBDT211.53138.53 53 PBT161.8990.08 80 NP127.5371.84 78Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 31 2025 | 2:29 PM IST